Evidence map›Paper›PMID 18800967›Full record

ReviewThe Biochemical journal2008

Mechanisms of neuronal death in disease: defining the models and the players.

Elena M Ribe, Esther Serrano-Saiz, Nsikan Akpan, Carol M Troy

Open access · greenAbstract readReview
In one paragraph

Review in The Biochemical journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Co-treatment with the seed ofFood science & nutrition · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  7. Review
  8. Article
  9. RSC advances · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. LncRNAs: New Players in Apoptosis Control.International journal of cell biology · 2014
    Review
  19. Article
  20. Caspase inhibitors: prospective therapies for stroke.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elena M RibeDepartment of Pathology, Taub Center for the Study of Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, 630 W. 168th Street, New York, NY 10032, USA.
Esther Serrano-Saiz
Nsikan Akpan
Carol M Troy
Columbia University · US

Funding

Downstream Regulators of Beta-Amyloid Induced Neuronal DeathR01NS043089 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TROY, CAROL M · 2001 to 2010
$2.2M
NEURONAL DEGENERATION: MECHANISMS AND PREVENTIONR01NS035933 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TROY, CAROL M · 2004 to 2007
$1.5M
Downstream Regulators of Beta-Amyloid Induced Neuronal DeathR56NS043089 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TROY, CAROL M · 2008 to 2008
$351k
NEURONAL DEGENERATION--MECHANISMS AND PREVENTIONR29NS035933 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TROY, CAROL M · 1997 to 2001
$237k
NINDS NIH HHS R01 NS035933NINDS NIH HHS R01 NS043089NINDS NIH HHS R29 NS035933NINDS NIH HHS R56 NS043089
6 · The paper itself

Abstract

Dysregulation of life and death at the cellular level leads to a variety of diseases. In the nervous system, aberrant neuronal death is an outstanding feature of neurodegenerative diseases. Since the discovery of the caspase family of proteases, much effort has been made to determine how caspases function in disease, including neurodegenerative diseases. Although many papers have been published examining caspases in neuronal death and disease, the pathways have not been fully clarified. In the present review, we examine the potential players in the death pathways, the current tools for examining these players and the models for studying neurological disease. Alzheimer's disease, the most common neurodegenerative disorder, and cerebral ischaemia, the most common cause of neurological death, are used to illustrate our current understanding of death signalling in neurodegenerative diseases. A better understanding of the neuronal death pathways would provide targets for the development of therapeutic interventions for these diseases.

Indexed as

Signal TransductionAlzheimer DiseaseAnimalsApoptosisBrain IschemiaCaspasesHumansModels, BiologicalNervous System DiseasesNeuronsCaspases

Identifiers

PMID18800967
PMCPMC9334905
OpenAlexW1980005230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.